353 related articles for article (PubMed ID: 38674143)
21. Electrophilic metabolites targeting the KEAP1/NRF2 partnership.
Dinkova-Kostova AT; Hakomäki H; Levonen AL
Curr Opin Chem Biol; 2024 Feb; 78():102425. PubMed ID: 38241876
[TBL] [Abstract][Full Text] [Related]
22. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
[TBL] [Abstract][Full Text] [Related]
23. Cholesterol Hydroperoxide Co-trafficking in Testosterone-generating Leydig Cells: GPx4 Inhibition of Cytotoxic and Anti-steroidogenic Effects.
Pabisz P; Bazak J; Sabat M; Girotti AW; Korytowski W
Cell Biochem Biophys; 2024 Mar; 82(1):213-222. PubMed ID: 37995086
[TBL] [Abstract][Full Text] [Related]
24. Short Survey on the Protein Modifications in Plasma during SARS-CoV-2 Infection.
Gęgotek A; Zarkovic N; Orehovec B; Jaganjac M; Sunjic SB; Skrzydlewska E
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762413
[TBL] [Abstract][Full Text] [Related]
25. The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities.
Yang G; Li C; Tao F; Liu Y; Zhu M; Du Y; Fei C; She Q; Chen J
Genes Dis; 2024 Mar; 11(2):645-663. PubMed ID: 37692513
[TBL] [Abstract][Full Text] [Related]
26. Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3/SLC7A11 pathway.
Nie J; Ling Y; Jin M; Chen Z; Liu W; Shen W; Fang T; Li J; He Y
Eur J Pharmacol; 2023 Oct; 957():176009. PubMed ID: 37619784
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.
Zheng Z; Su J; Bao X; Wang H; Bian C; Zhao Q; Jiang X
Front Immunol; 2023; 14():1247268. PubMed ID: 37600785
[TBL] [Abstract][Full Text] [Related]
28. The expanding organelle lipidomes: current knowledge and challenges.
Sarmento MJ; Llorente A; Petan T; Khnykin D; Popa I; Nikolac Perkovic M; Konjevod M; Jaganjac M
Cell Mol Life Sci; 2023 Aug; 80(8):237. PubMed ID: 37530856
[TBL] [Abstract][Full Text] [Related]
29. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1.
Jiang M; Jike Y; Liu K; Gan F; Zhang K; Xie M; Zhang J; Chen C; Zou X; Jiang X; Dai Y; Chen W; Qiu Y; Bo Z
Mol Cancer; 2023 Jul; 22(1):113. PubMed ID: 37461104
[TBL] [Abstract][Full Text] [Related]
30. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma.
Guo W; Wang X; Lu B; Yu J; Xu M; Huang R; Cheng M; Yang M; Zhao W; Zou C
Cell Death Dis; 2023 Jul; 14(7):439. PubMed ID: 37460542
[TBL] [Abstract][Full Text] [Related]
31. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
32. Click chemistry-based thiol redox proteomics reveals significant cysteine reduction induced by chronic ethanol consumption.
Harris PS; McGinnis CD; Michel CR; Marentette JO; Reisdorph R; Roede JR; Fritz KS
Redox Biol; 2023 Aug; 64():102792. PubMed ID: 37390786
[TBL] [Abstract][Full Text] [Related]
33. Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence.
Nizami ZN; Aburawi HE; Semlali A; Muhammad K; Iratni R
Antioxidants (Basel); 2023 May; 12(6):. PubMed ID: 37371889
[TBL] [Abstract][Full Text] [Related]
34. Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway.
Liu Z; Wang X; Li J; Yang X; Huang J; Ji C; Li X; Li L; Zhou J; Hu Y
Chem Biol Interact; 2023 Sep; 382():110602. PubMed ID: 37302459
[TBL] [Abstract][Full Text] [Related]
35. Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation-Cancer Interface.
Stone TW; Williams RO
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296860
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of an oxidative stress‑related prognostic signature in osteosarcoma: A combination of molecular experiments and bioinformatics.
Xie B; Tan S; Li C; Liang J
Oncol Lett; 2023 Jul; 26(1):279. PubMed ID: 37274481
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced oxidative stress in cancer treatments: Angel or devil?
Jiang H; Zuo J; Li B; Chen R; Luo K; Xiang X; Lu S; Huang C; Liu L; Tang J; Gao F
Redox Biol; 2023 Jul; 63():102754. PubMed ID: 37224697
[TBL] [Abstract][Full Text] [Related]
38. Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma.
Farooq A; Zulfiqar B; Asghar K
J Cancer Allied Spec; 2023; 9(1):501. PubMed ID: 37197000
[TBL] [Abstract][Full Text] [Related]
39. The Multifaceted Role of Glutathione S-Transferases in Health and Disease.
Mazari AMA; Zhang L; Ye ZW; Zhang J; Tew KD; Townsend DM
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189435
[TBL] [Abstract][Full Text] [Related]
40. Phenethyl isothiocyanate induces oxidative cell death in osteosarcoma cells with regulation on mitochondrial network, function and metabolism.
Zhen C; Li J; Liu J; Lyu Y; Xie L; Lv H
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166740. PubMed ID: 37142133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
